Blood Purification Equipment Market Size, Demand, Report to 2033

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Blood Purification Equipment Market Size Analysis

Global Blood Purification Equipment Market Introduction
By Product
1. Introduction
  1. Product By Value
2. Portable
  1. By Value
3. Stationary
  1. By Value
By Procedure
1. Introduction
  1. Procedure By Value
2. Dialysis
  1. By Value
3. Continuous Renal Replacement Therapy (CRRT)
  1. By Value
4. Hemoperfusion
  1. By Value
5. Others
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. Sepsis
  1. By Value
3. Renal Diseases
  1. By Value
4. Others
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Hospitals and Clinics
  1. By Value
3. Dialysis Centers
  1. By Value
4. Homecare Settings
  1. By Value
5. Others
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. Dialysis
  1. By Value
3. CRRT
  1. By Value
4. Hemoperfusion
  1. By Value
5. Others (Plasma Exchange and Immunoadsorption)
  1. By Value

North America Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Portable
  1. By Value
3. Stationary
  1. By Value
By Procedure
1. Introduction
  1. Procedure By Value
2. Dialysis
  1. By Value
3. Continuous Renal Replacement Therapy (CRRT)
  1. By Value
4. Hemoperfusion
  1. By Value
5. Others
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. Sepsis
  1. By Value
3. Renal Diseases
  1. By Value
4. Others
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Hospitals and Clinics
  1. By Value
3. Dialysis Centers
  1. By Value
4. Homecare Settings
  1. By Value
5. Others
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. Dialysis
  1. By Value
3. CRRT
  1. By Value
4. Hemoperfusion
  1. By Value
5. Others (Plasma Exchange and Immunoadsorption)
  1. By Value
U.S.
1. By Product
  1. Introduction
    1. Product By Value
  2. Portable
    1. By Value
  3. Stationary
    1. By Value
2. By Procedure
  1. Introduction
    1. Procedure By Value
  2. Dialysis
    1. By Value
  3. Continuous Renal Replacement Therapy (CRRT)
    1. By Value
  4. Hemoperfusion
    1. By Value
  5. Others
    1. By Value
3. By Indication
  1. Introduction
    1. Indication By Value
  2. Sepsis
    1. By Value
  3. Renal Diseases
    1. By Value
  4. Others
    1. By Value
4. By End User
  1. Introduction
    1. End User By Value
  2. Hospitals and Clinics
    1. By Value
  3. Dialysis Centers
    1. By Value
  4. Homecare Settings
    1. By Value
  5. Others
    1. By Value
5. By Type
  1. Introduction
    1. Type By Value
  2. Dialysis
    1. By Value
  3. CRRT
    1. By Value
  4. Hemoperfusion
    1. By Value
  5. Others (Plasma Exchange and Immunoadsorption)
    1. By Value
Canada

Europe Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Portable
  1. By Value
3. Stationary
  1. By Value
By Procedure
1. Introduction
  1. Procedure By Value
2. Dialysis
  1. By Value
3. Continuous Renal Replacement Therapy (CRRT)
  1. By Value
4. Hemoperfusion
  1. By Value
5. Others
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. Sepsis
  1. By Value
3. Renal Diseases
  1. By Value
4. Others
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Hospitals and Clinics
  1. By Value
3. Dialysis Centers
  1. By Value
4. Homecare Settings
  1. By Value
5. Others
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. Dialysis
  1. By Value
3. CRRT
  1. By Value
4. Hemoperfusion
  1. By Value
5. Others (Plasma Exchange and Immunoadsorption)
  1. By Value
U.K.
1. By Product
  1. Introduction
    1. Product By Value
  2. Portable
    1. By Value
  3. Stationary
    1. By Value
2. By Procedure
  1. Introduction
    1. Procedure By Value
  2. Dialysis
    1. By Value
  3. Continuous Renal Replacement Therapy (CRRT)
    1. By Value
  4. Hemoperfusion
    1. By Value
  5. Others
    1. By Value
3. By Indication
  1. Introduction
    1. Indication By Value
  2. Sepsis
    1. By Value
  3. Renal Diseases
    1. By Value
  4. Others
    1. By Value
4. By End User
  1. Introduction
    1. End User By Value
  2. Hospitals and Clinics
    1. By Value
  3. Dialysis Centers
    1. By Value
  4. Homecare Settings
    1. By Value
  5. Others
    1. By Value
5. By Type
  1. Introduction
    1. Type By Value
  2. Dialysis
    1. By Value
  3. CRRT
    1. By Value
  4. Hemoperfusion
    1. By Value
  5. Others (Plasma Exchange and Immunoadsorption)
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Portable
  1. By Value
3. Stationary
  1. By Value
By Procedure
1. Introduction
  1. Procedure By Value
2. Dialysis
  1. By Value
3. Continuous Renal Replacement Therapy (CRRT)
  1. By Value
4. Hemoperfusion
  1. By Value
5. Others
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. Sepsis
  1. By Value
3. Renal Diseases
  1. By Value
4. Others
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Hospitals and Clinics
  1. By Value
3. Dialysis Centers
  1. By Value
4. Homecare Settings
  1. By Value
5. Others
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. Dialysis
  1. By Value
3. CRRT
  1. By Value
4. Hemoperfusion
  1. By Value
5. Others (Plasma Exchange and Immunoadsorption)
  1. By Value
China
1. By Product
  1. Introduction
    1. Product By Value
  2. Portable
    1. By Value
  3. Stationary
    1. By Value
2. By Procedure
  1. Introduction
    1. Procedure By Value
  2. Dialysis
    1. By Value
  3. Continuous Renal Replacement Therapy (CRRT)
    1. By Value
  4. Hemoperfusion
    1. By Value
  5. Others
    1. By Value
3. By Indication
  1. Introduction
    1. Indication By Value
  2. Sepsis
    1. By Value
  3. Renal Diseases
    1. By Value
  4. Others
    1. By Value
4. By End User
  1. Introduction
    1. End User By Value
  2. Hospitals and Clinics
    1. By Value
  3. Dialysis Centers
    1. By Value
  4. Homecare Settings
    1. By Value
  5. Others
    1. By Value
5. By Type
  1. Introduction
    1. Type By Value
  2. Dialysis
    1. By Value
  3. CRRT
    1. By Value
  4. Hemoperfusion
    1. By Value
  5. Others (Plasma Exchange and Immunoadsorption)
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Portable
  1. By Value
3. Stationary
  1. By Value
By Procedure
1. Introduction
  1. Procedure By Value
2. Dialysis
  1. By Value
3. Continuous Renal Replacement Therapy (CRRT)
  1. By Value
4. Hemoperfusion
  1. By Value
5. Others
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. Sepsis
  1. By Value
3. Renal Diseases
  1. By Value
4. Others
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Hospitals and Clinics
  1. By Value
3. Dialysis Centers
  1. By Value
4. Homecare Settings
  1. By Value
5. Others
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. Dialysis
  1. By Value
3. CRRT
  1. By Value
4. Hemoperfusion
  1. By Value
5. Others (Plasma Exchange and Immunoadsorption)
  1. By Value
UAE
1. By Product
  1. Introduction
    1. Product By Value
  2. Portable
    1. By Value
  3. Stationary
    1. By Value
2. By Procedure
  1. Introduction
    1. Procedure By Value
  2. Dialysis
    1. By Value
  3. Continuous Renal Replacement Therapy (CRRT)
    1. By Value
  4. Hemoperfusion
    1. By Value
  5. Others
    1. By Value
3. By Indication
  1. Introduction
    1. Indication By Value
  2. Sepsis
    1. By Value
  3. Renal Diseases
    1. By Value
  4. Others
    1. By Value
4. By End User
  1. Introduction
    1. End User By Value
  2. Hospitals and Clinics
    1. By Value
  3. Dialysis Centers
    1. By Value
  4. Homecare Settings
    1. By Value
  5. Others
    1. By Value
5. By Type
  1. Introduction
    1. Type By Value
  2. Dialysis
    1. By Value
  3. CRRT
    1. By Value
  4. Hemoperfusion
    1. By Value
  5. Others (Plasma Exchange and Immunoadsorption)
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Portable
  1. By Value
3. Stationary
  1. By Value
By Procedure
1. Introduction
  1. Procedure By Value
2. Dialysis
  1. By Value
3. Continuous Renal Replacement Therapy (CRRT)
  1. By Value
4. Hemoperfusion
  1. By Value
5. Others
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. Sepsis
  1. By Value
3. Renal Diseases
  1. By Value
4. Others
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Hospitals and Clinics
  1. By Value
3. Dialysis Centers
  1. By Value
4. Homecare Settings
  1. By Value
5. Others
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. Dialysis
  1. By Value
3. CRRT
  1. By Value
4. Hemoperfusion
  1. By Value
5. Others (Plasma Exchange and Immunoadsorption)
  1. By Value
Brazil
1. By Product
  1. Introduction
    1. Product By Value
  2. Portable
    1. By Value
  3. Stationary
    1. By Value
2. By Procedure
  1. Introduction
    1. Procedure By Value
  2. Dialysis
    1. By Value
  3. Continuous Renal Replacement Therapy (CRRT)
    1. By Value
  4. Hemoperfusion
    1. By Value
  5. Others
    1. By Value
3. By Indication
  1. Introduction
    1. Indication By Value
  2. Sepsis
    1. By Value
  3. Renal Diseases
    1. By Value
  4. Others
    1. By Value
4. By End User
  1. Introduction
    1. End User By Value
  2. Hospitals and Clinics
    1. By Value
  3. Dialysis Centers
    1. By Value
  4. Homecare Settings
    1. By Value
  5. Others
    1. By Value
5. By Type
  1. Introduction
    1. Type By Value
  2. Dialysis
    1. By Value
  3. CRRT
    1. By Value
  4. Hemoperfusion
    1. By Value
  5. Others (Plasma Exchange and Immunoadsorption)
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Blood Purification Equipment Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Infomed SA
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Braun Melsungen AG
Baxter International Inc.
Nikkiso Co.Ltd
Jafron Biomedical Co.Ltd.
SWS Hemodialysis Co.,ltd
Fresenius SE & Co. KGaA
Kaneka Corporation
ExThera Medical Corporation
Baihe Medical
Cytosorbents Corporation
Marker Therapeutics AG
Medica S.p.A.
Dialife SA

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment